Patrick Machado - 02 Jun 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role
Director
Signature
/s/ Annette North, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Jun 2021
Net transactions value
$0
Form type
4
Filing time
04 Jun 2021, 17:41:28 UTC
Previous filing
14 May 2021
Next filing
03 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Award $0 +8,500 $0.000000 8,500 02 Jun 2021 Common Stock 8,500 $65.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest on the one-year anniversary of the date of grant.